In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Equipment, Disposable Devices, Culture Media), By Procedure Type (Fresh Nondonor, Frozen Nondonor), By Providers, By Region, And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the in vitro fertilization market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for in vitro fertilization market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of in vitro fertilization market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

In Vitro Fertilization Market Categorization:

The in vitro fertilization market was categorized into four segments, namely product (Security & Access Controls, Lighting Control, Entertainment Devices, HVAC, Smart Kitchen Appliances, Home Appliances, Smart Furniture, Home Healthcare), protocols (Wireless Protocols, Wired Protocols, Hybrid), application (New Construction, Retrofit), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The in vitro fertilization market was segmented into product, protocols, application, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The in vitro fertilization market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-five countries, namely, the U.S.; Canada; France; Germany; Italy; Spain; the UK; Belgium; Netherlands; Switzerland; Norway; Denmark; Sweden; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

In vitro fertilization market companies & financials:

The in vitro fertilization market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• OvaScience, Inc. - OvaScience, Inc. is involved in upgrading treatment options for women. The company discovers, develops, and commercializes new fertility options, such as Egg Precursor (EggPCSM), that help increase the chances of conceiving.

• FUJIFILM Irvine Scientific - FUJIFILM Irvine Scientific is a member of Fujifilm Holdings Corporation. The company manufactures cell media cultures, reagents & medical devices for researchers & clinicians. It specializes in Assisted Reproductive Technology (ART), cytogenetics, biologics & biosimilar, specialty media products, cell culture media, and cell therapy.

• Emd Serono, Inc. - EMD Serono, Inc. is a subsidiary of Merck KGaA, acquired in 2006. Since then, the biopharmaceutical segment of Merck KGaA has been recognized as EMD Serono in the U.S. and Canada.

• Thermo Fisher Scientific, Inc. - Thermo Fisher Scientific, Inc. is a biotechnology and product development company. In 2013, the company acquired Life Technologies Corporation to become one of the leading providers of genetic testing & laboratory equipment solutions. The company offers innovative technologies and services through Applied Biosystems, Thermo Scientific, Fisher Scientific, Invitrogen, and Unity Lab Services.

• Bayer AG - Bayer AG is a pharmaceutical & chemical company with more than 150 years of experience in healthcare. Bayer’s core business includes human pharmaceuticals, veterinary pharmaceuticals, human healthcare products, biotechnology products, and agricultural chemicals. Bayer Healthcare specializes in general & specialty medicines. . The pharmaceutical product portfolio consists of prescription products for cardiology & women’s health; specialty therapeutics in oncology, hematology, & ophthalmology; and contrast-enhanced diagnostic imaging equipment & contrast agents in radiology.

• Merck & Co., Inc. - Merck & Co., Inc. is a global healthcare company that offers prescription medicines, biologic therapies, vaccines, and animal health products. The company operates through four business segments—pharmaceuticals, animal health, healthcare services, and alliances. The company is involved in clinical research of various conditions such as cancer, hepatitis C, cardiometabolic diseases, antibioticresistant infection, & Alzheimer's disease.

• Cook Medical LLC - Cook Medical LLC is a part of Cook Group in Bloomington, Indiana. It primarily manufactures medical, surgical, ophthalmic, and reproductive health products. The company operates mainly in two divisions—Vascular and MedSurg. The reproductive health segment under the MedSurg division offers products for IVF.

• Genea Biomedx - Genea Biomedx, a fertility and IVF clinic, is a part of the Genea family. It designs & manufactures IVF devices to standardize and automate fertility treatments. Genea is Australia's third-largest reproductive services player.

• Progyny, Inc. - Progyny, Inc., is a leading fertility benefits management company in the U.S. The company operates in the healthcare industry and focuses on fertility & family building benefits. Progyny deals with large employers to provide fertility and family-building benefits.

• Boston IVF - Boston IVF is a fertility clinic that offers services, including egg donation, egg freezing, and embryo donation. These services are offered through procedures such as IUI & IVF. The clinic introduced Signature Success, a feature through which it offers tailored treatments and evaluation processes for patient care.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

In Vitro Fertilization Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2023, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

In Vitro Fertilization Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.